Basic Information
| LncRNA/CircRNA Name | RP11-159K7.2 |
| Synonyms | NA |
| Region | GRCh38_5:112628436-112632100 |
| Ensemble | NA |
| Refseq | NA |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | laryngeal squamous cell cancer |
| ICD-0-3 | C32.3 |
| Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. |
| Sample | LSCC and adjacent non-tumorous tissues, cells lines (TU-212, AMC-HN-8, HEK-293T) |
| Expression Pattern | up-regulated |
| Function Description | Mechanically, we found that RP11-159K7.2 could positively regulate the expression of DNMT3A by sponging miR-206. In addition, a feedback loop was also discovered between DNMT3A and miR-206. To sum up, these findings suggest that lncRNA RP11-159K7.2 could be used as a potential biomarker for prognosis and treatment of LSCC. |
| Pubmed ID | 32363688 |
| Year | 2020 |
| Title | Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis. |
External Links
| Links for RP11-159K7.2 | GenBank HGNC Noncode |
| Links for laryngeal squamous cell cancer | Omim Cosmic |